PEAK6 Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$290K Buy
+20,800
New +$351K ﹤0.01% 3044
2016
Q2
Sell
-23,207
Closed -$779K 4651
2016
Q1
$779K Sell
23,207
-6,054
-21% -$191K 0.01% 1902
2015
Q4
$874K Sell
29,261
-38,443
-57% -$1.3M 0.01% 2061
2015
Q3
$2.13M Sell
67,704
-2,623
-4% -$128K 0.01% 1530
2015
Q2
$3.4M Buy
70,327
+48,877
+228% +$2.06M 0.02% 1087
2015
Q1
$930K Sell
21,450
-77,847
-78% -$2.8M 0.01% 1944
2014
Q4
$2.61M Buy
99,297
+8,789
+10% +$193K 0.02% 1094
2014
Q3
$1.61M Sell
90,508
-16,950
-16% -$346K 0.01% 1435
2014
Q2
$2.58M Buy
107,458
+76,591
+248% +$1.55M 0.02% 907
2014
Q1
$776K Sell
30,867
-22,391
-42% -$620K 0.01% 2095
2013
Q4
$1.21M Buy
+53,258
New +$1.08M 0.01% 1894

Other funds holding PGEN

PEAK6 Group's PGEN Position: Q1 2016 in Review

PEAK6 Group sold out of Precigen (PGEN) in Q1 2016, closing a stake of 37,204 shares — an estimated $1.17M sold.

PEAK6 Group first reported a position in PGEN in Q3 2013 and held it in 4 quarters. The position peaked at $1.85M in Q3 2013. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • PEAK6 Group reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 37,204 Precigen shares in Q1 2016, an estimated $1.17M.
  • PEAK6 Group first reported a position in Precigen in Q3 2013 and held it in 4 quarters.
  • PEAK6 Group's Precigen position peaked at $1.85M in Q3 2013.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.